The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N03 | Antiepileptics | |
| 3 | N03A | Antiepileptics | |
| 4 | N03AE | Benzodiazepine derivatives |
| Code | Title | |
|---|---|---|
| N03AE01 | Clonazepam |
| Active Ingredient | Description | |
|---|---|---|
| Clonazepam |
Clonazepam exhibits pharmacological properties which are common to benzodiazepines and include anticonvulsive, sedative, muscle relaxing and anxiolytic effects. Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absence seizures (petit mal), slow spike wave, generalised spike wave, spikes with temporal or other locations as well as irregular spikes and waves. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| AKLONIL Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| RIVOTRIL Concentrate for solution for injection / infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| RIVOTRIL Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
